48 reports

Abstract: - Global Anxiety Disorder Treatment Market to Reach $7.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anxiety Disorder Treatment estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at a CAGR of 1.3% over the analysis period...

  • Anxiety Disorder
  • World
  • China
  • United States

Top Companies Participating in Social Anxiety Disorder (SAD/Social Phobia) Therapeutics Clinical Trials

  • Anxiety Disorder
  • Clinical Trial
  • World
  • Europe
  • G7
  • APAC
  • Diagnostic Imaging Density

‘Generalized Anxiety Disorder (GAD)- Market Insights, Epidemiology, and Market Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Generalized Anxiety Disorder in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan....

  • Anxiety Disorder
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anxiety Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Neurology
  • Anxiety Disorder
  • World

Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 Summary Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Generalized Anxiety Disorder (GAD) pipeline landscape. The report provides comprehensive...

  • Anxiety Disorder
  • Neurology
  • World

The ongoing clinical trial research report- “2019 Social Anxiety Disorders (SAD) Ongoing Clinical Trials Study” analyzes the current scenario of all active Social Anxiety Disorders (SAD) trials across the world. The report presents top level analysis of global Social Anxiety Disorders (SAD) clinical trials across countries, companies and universities....

  • Anxiety Disorder
  • Clinical Trial
  • World
  • APAC

Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021 Summary Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Social Anxiety Disorder (SAD/Social Phobia) pipeline landscape. The...

  • Anxiety Disorder
  • World

Abstract: - Global Antidepressants Market to Reach $15.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antidepressants estimated at US$14.2 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at a CAGR of 1% over the analysis period 2020-2027. Major...

  • Antidepressant
  • Anxiety Disorder
  • World
  • China
  • United States

## Depression and Anxiety Disorders Report Coverage

  • Depression
  • Anxiety Disorder
  • Indiana
  • Drug Approval
  • Prescription Drug Sales

Small Molecules to Antagonize MGLUR## for Anxiety Disorders – Drug Profile

  • Mental Health
  • Psychotic Disorder
  • Pharmaceutical
  • Drug Development
  • Therapy
  • Neurological Disorder
  • Anxiety Disorder
  • World
  • Diagnostic Imaging Density
  • Illicit Drug Use

“Generalized Anxiety Disorder (GAD) – Pipeline Insight, 2020,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Generalized Anxiety Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Anxiety Disorder
  • World

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Behavioral Rehabilitation Market By Application (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Personality Disorder, Attention...

  • Mental Health
  • Specialty Hospital
  • Depression
  • Anxiety Disorder
  • World
  • Depression Prevalence

Report Scope: The report offers an exhaustive description and evaluation of the global stress management market.It provides in-depth qualitative and quantitative insights into the report, which aligns with the goals and objectives of our intended customers. The projections are verified through intensive primary and...

  • Anxiety Disorder
  • Personality Disorder
  • World
  • Elderly Population
  • Paid Claims

The global clinical trial report- “2019 Social Anxiety Disorders (SAD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Social Anxiety Disorders (SAD). It presents in-depth analysis of Social Anxiety Disorders (SAD) clinical trials across markets and companies. The research work is for providing complete...

  • Anxiety Disorder
  • Clinical Trial
  • World

Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Atypical Antipsychotics, Tricyclic Antidepressants (TCAs), Serotonin Antagonist and Reuptake Inhibitors (SARIs), Benzodiazepines; Monoamine Oxidase Inhibitors (MAOIs), Major Depressive Disorder (MDD), General Anxiety Disorder (GAD),...

  • Antidepressant
  • Anxiety Disorder
  • Hormone
  • World

Small Molecules to Antagonize MGLUR## for Anxiety Disorders – Drug Profile

  • Psychotic Disorder
  • Drug Development
  • Therapy
  • Neurological Disorder
  • Mental Health
  • Anxiety Disorder
  • World
  • Diagnostic Imaging Density
  • Illicit Drug Use

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Psychiatry partnering deals Financial deal terms for headline, upfront and royalty by stage of development Psychiatry partnering...

  • Neurological Disorder
  • Anxiety Disorder
  • Dementia
  • Sleep Aid
  • Personality Disorder
  • World

Small Molecules to Antagonize MGLUR## for Anxiety Disorders – Drug Profile

  • Neurological Disorder
  • Drug Development
  • Therapy
  • Mental Health
  • Pharmaceutical
  • Anxiety Disorder
  • World
  • Diagnostic Imaging Density
  • Illicit Drug Use

This study covers the world outlook for anxiety disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Anxiety Disorder
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for anxiety disorders and depression treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Anxiety Disorder
  • Antidepressant
  • World
  • Gross Domestic Product
  • Disposable Income

Small Molecules to Antagonize MGLUR## for Anxiety Disorders – Drug Profile

  • Neurological Disorder
  • Drug Development
  • Therapy
  • Mental Health
  • Anxiety Disorder
  • Pharmaceutical
  • World
  • Diagnostic Imaging Density
  • Illicit Drug Use

Anxiety Disorder

  • Anxiety Disorder
  • World
  • Prescription Drug Sales
  • Hospital Admission

World Anxiety Disorder

  • Chronic Pain
  • Therapy
  • Anxiety Disorder
  • World
  • Alcohol Excessive Use
  • Medicine Use

World Anxiety Disorder

  • Chronic Pain
  • Therapy
  • Anxiety Disorder
  • World
  • Health Provider Density
  • Medicine Use

General Anxiety Disorder ongoing clinical trials report provides comprehensive analysis and trends in global General Anxiety Disorder disease clinical trials. The research work analyzes the ongoing General Anxiety Disorder clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated...

  • Clinical Trial
  • Anxiety Disorder
  • World

Social Anxiety Disorders (SAD) ongoing clinical trials report provides comprehensive analysis and trends in global Social Anxiety Disorders (SAD) disease clinical trials. The research work analyzes the ongoing Social Anxiety Disorders (SAD) clinical trial trends across countries and companies. The report focuses on drugs and therapies...

  • Anxiety Disorder
  • Clinical Trial
  • World

World Therapy Anxiety Disorder

  • Anxiety Disorder
  • World
  • Drug Approval
  • Illicit Drug Use

Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist...

  • Hormone
  • Anxiety Disorder
  • Antidepressant
  • World

World Anxiety Disorder

  • Anxiety Disorder
  • World
  • Health Provider Density
  • Illicit Drug Use

Pherin Pharmaceuticals, Inc. announced that a Phase II clinical trial showed that its proprietary compound PH##B demonstrated significant benefits in the acute treatment of symptoms of Social Anxiety Disorder (Social Phobia).

  • Anxiety Disorder
  • World
  • United States
  • North America
  • Health Provider Density
  • Drug Approval